ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 251 filers reported holding ADMA BIOLOGICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,002,846 | +24.5% | 89,700 | -26.5% | 0.03% | +36.0% |
| Q1 2024 | $805,299 | +13.8% | 122,015 | -22.1% | 0.02% | +13.6% |
| Q4 2023 | $707,927 | +23.5% | 156,621 | -2.2% | 0.02% | +10.0% |
| Q3 2023 | $573,409 | -3.0% | 160,170 | 0.0% | 0.02% | +5.3% |
| Q2 2023 | $591,027 | -4.9% | 160,170 | -14.7% | 0.02% | -9.5% |
| Q1 2023 | $621,529 | +85157.8% | 187,773 | 0.0% | 0.02% | -19.2% |
| Q4 2022 | $729 | -99.9% | 187,773 | -29.4% | 0.03% | +4.0% |
| Q3 2022 | $647,000 | +16.4% | 266,129 | -5.2% | 0.02% | +25.0% |
| Q2 2022 | $556,000 | -19.2% | 280,636 | -25.3% | 0.02% | -4.8% |
| Q1 2022 | $688,000 | -5.0% | 375,781 | -26.8% | 0.02% | 0.0% |
| Q4 2021 | $724,000 | – | 513,591 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |